Shareholder Information
    & Services

    1. Investors
    2. Shareholder Information
    3. Share Capital

    Shareholder Information

    Share Capital build-up since inception

    DateNo. of equity shares allottedFace Value (₹)Issue Price (₹)ConsiderationReasons/ Mode of allotmentCumulative Paid-Up Capital (₹)Cumulative no. of Shares
    April 26, 19471,000100100CashInitial subscribers to the Memorandum of Association100,0001,000
    June 30, 19675,000100–CashEquity shares allotted pursuant to a bonus issue600,0006,000
    August 28,1979Sub-division of the equity shares from face value of ₹ 100 each to face value of ₹ 10 each600,00060,000
    October 4, 1979600,00010–N.A.Equity shares allotted pursuant to a bonus issue6,600,000660,000
    November, 1979803,6001010CashEquity shares allotted pursuant to rights issue14,636,0001,463,600
    June 3, 19911,650,00010–Other than cashAllotment to shareholders of erstwhile Gujarat Glass Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 195631,136,0003,113,600
    September 30, 19913,113,60010–N.A.Equity shares allotted pursuant to a bonus issue to the then existing shareholders62,272,0006,227,200
    October 20, 19921,879,8361050CashEquity shares allotted pursuant to conversion of partly convertible debentures81,070,3608,107,036
    July 29, 19934,053,51810–N.A.Equity shares allotted pursuant to a bonus issue121,605,54012,160,554
    February 14, 17 and 19, 19943,030,00010330CashPreferential allotment to 22 allotees151,905,54015,190,554
    August 4, 19942,200,0001090CashIssued against warrants attached to non-convertible debentures173,905,54017,390,554
    September 16, 19961,039,41010–Other than cashAllotment to shareholders of erstwhile Sumitra Pharmaceuticals & Chemicals Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956184,299,64018,429,964
    October 10, 19979,278,40610–Other than cashAllotment of 7,505,004 equity shares to shareholders of erstwhile Piramal Healthcare Limited and 1,773,402 equity shares to shareholders of erstwhile Boehringer Mannheim India Limited, pursuant to respective schemes of arrangement under Sections 391-394 of the Companies Act, 1956277,083,70027,708,370
    February 15, 20007,137,7811050CashIssued against the conversion of warrants held by shareholders of erstwhile Piramal Holdings Limited348,461,51034,846,151
    March 29, 20006,9001050CashIssued against the conversion of warrants held by shareholders of our Company348,530,51034,853,051
    August 9, 20001501050CashIssued to G. Ratnavali, one of then shareholder of our Company against the conversion of warrants held by him.348,532,01034,853,201
    February 15, 20023,150,00010–Other than cashAllotment to shareholders of Rhone-Poulenc (India) Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956380,032,01038,003,201
    January 3, 2005Subdivision of the equity shares from face value of ₹ 10 to face value of ₹ 2 each380,032,010190,016,005
    September 25, 200518,997,1282175CashEquity Shares allotted pursuant to rights issue418,026,266209,013,133
    July 16, 2007112175CashEquity Shares allotted out of the Equity Shares held in abeyance during the rights issue dated September 25, 2005418,026,288209,013,144
    March 29, 2011-41,097,1002600CashBuy back of Equity Shares335,832,088167,916,044
    June 15, 2011-705,5292600CashBuy back of Equity Shares334,421,030167,210,515
    December 30, 20115,352,58522Other than cashAllotment to shareholders of Piramal Life Sciences Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956345,126,200172,563,100
    November 24, 2017225,0002–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company345,576,200172,788,100
    March 8, 20187,485,57422380CashEquity shares allotted pursuant to rights issue360,547,348180,273,674
    May 7, 2018121,2002–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company360,789,748180,394,874
    May 15, 2018197,6402–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company361,185,028180,592,514
    July 5, 2018526922380CashAllotment pursuant of shares out of CCD reservation portion under rights issue of the Company361,195,566180,597,783
    August 31, 20182002–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company361,195,966180,597,983
    September 7,201885,2802–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company361,366,526180,683,263
    September 17,20183,71522380CashAllotment pursuant of shares out of CCD reservation portion under rights issue of the Company361,373,956180,686,978
    September 25,2018302,0002–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company361,977,956180,988,978
    October 5,2018322,2402–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company362,622,436181,311,218
    October 26,20181,373,2402–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company365,368,916182,684,458
    November 16,2018675,3602–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company366,719,636183,359,818
    December 18,201852,4402–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company36,68,24,51618,34,12,258
    January 16, 2019186,0002–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company36,71,96,51618,35,98,258
    February 4, 2019441,9202–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company36,80,80,35618,40,40,178
    March 14, 2019404,4802–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company36,88,89,31618,44,44,658
    March 19, 20192,31422,380CashEquity Shares allotted out of the Right Shares held in abeyance under the rights issue of the Company36,88,93,94418,44,46,972
    April 05, 201917,58522,380CashAllotment pursuant of shares out of CCD reservation portion under rights issue of the Company36,89,29,11418,44,64,557
    April 11, 20195,48,1202–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company37,00,25,35418,50,12,677
    April 22, 20191,36,38,0802–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company39,73,01,51419,86,50,757
    May 21, 20191,93,55022,380CashAllotment pursuant of shares out of CCD reservation portion under rights issue of the Company39,76,88,61419,88,44,307
    May 30, 20192,25722,380CashAllotment pursuant of shares out of CCD reservation portion under rights issue of the Company39,76,93,12819,88,46,564
    August 08, 20196622,380CashEquity Shares allotted out of the Right Shares held in abeyance under the rights issue of the Company39,76,93,26019,88,46,630
    December 13,20193,05,8652–Other than cashAllotment pursuant to the Scheme of Amalgamation of Piramal Phytocare Limited with Piramal Enterprises Limited39,83,04,990199,152,495
    January 29, 20202,63,85,86121300CashEquity Shares allotted pursuant to rights issue vide Letter of Offer dated December 24, 201945,10,76,71222,55,38,356
    June 14, 20211,15,89,4002–Other than cashAllotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company47,42,55,51223,71,27,756
    June 28, 202115,35,94421300CashAllotment of shares out of CCD reservation portion under rights issue of the Company47,73,27,40023,86,63,700
    September 18, 2023-1,40,00,00021250CashBuy back of Equity Shares44,93,27,40022,46,63,700

    © 2024 Piramal Enterprises Ltd.